GoggleDocs (@goggledocs) 's Twitter Profile
GoggleDocs

@goggledocs

πŸ₯½πŸ©ΊDocs/nurses/pharmacists from U.K. Talking CardioRenoMetabolic & more Catch us on YouTube youtube.com/c/GoggleDocs |Educate, Motivate, Activate!

ID: 1313928734144188419

calendar_today07-10-2020 19:46:43

2,2K Tweet

3,3K Followers

2,2K Following

GoggleDocs (@goggledocs) 's Twitter Profile Photo
GoggleDocs
@goggledocs

a month ago

πŸ“’ Tirzepatide vs Semaglutide: the heavyweight match lands hard πŸ”Ή 72w RCT in obesity (no T2D): – Tirzepatide ‡️ –20.2% – Semaglutide ‡️ –13.7% πŸ”Έ Waist ‡️ –18.4cm vs –13.0cm πŸ”Ή More likely to hit β©Ύ25% loss: 32% vs 16% πŸ”Έ GI AEs common, but discontinuation <10% πŸ‘‰ Dual

πŸ“’ Tirzepatide vs Semaglutide: the heavyweight match lands hard πŸ”Ή 72w RCT in obesity (no T2D): – Tirzepatide ‡️ –20.2% – Semaglutide ‡️ –13.7% πŸ”Έ Waist ‡️ –18.4cm vs –13.0cm πŸ”Ή More likely to hit β©Ύ25% loss: 32% vs 16% πŸ”Έ GI AEs common, but discontinuation &lt;10% πŸ‘‰ Dual